VAT1L Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88568
Key Product Details
Species Reactivity
Human, Mouse
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of VAT1L. Peptide sequence: FIDLMVRQGNIDNPPKTPLVPGFECSGIVEALGDSVKGYEIGDRVMAFVN The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for VAT1L Antibody
Western Blot: VAT1L Antibody [NBP2-88568]
Western Blot: VAT1L Antibody [NBP2-88568] - WB Suggested Anti-Vat1l Antibody. Titration: 1.0 ug/ml. Positive Control: Mouse KidneyWestern Blot: VAT1L Antibody [NBP2-88568]
Western Blot: VAT1L Antibody [NBP2-88568] - WB Suggested Anti-Vat1l Antibody. Positive Control: Lane 1: 60ug human NT2 cell line Lane 2: 80ug mouse brain extract. Primary Antibody Dilution : 1:500. Secondary Antibody : IRDye 800 CW goat anti-rabbit from Li-COR Bioscience. Secondry Antibody DilutionApplications for VAT1L Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: VAT1L
Alternate Names
KIAA1576synaptic vesicle membrane protein VAT-1 homolog-like, vesicle amine transport protein 1 homolog (T. californica)-like, vesicle amine transport protein 1 homolog-like (T. californica)
Gene Symbol
VAT1L
Additional VAT1L Products
Product Specific Notices for VAT1L Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...